Strategic Intelligence Equips Cardiovascular Client to Navigate Market Disruption from New Entrants and Generics

Sedulo GroupCase Studies

A U.S.-based biopharmaceutical company faced competitive pressure from upcoming cardiovascular product launches and looming generic entry. Sedulo Group delivered targeted intelligence on competitor strategies, generic threats, and market vulnerabilities through a customized monitoring program. Armed with these insights, the client implemented counter-launch tactics, adjusted pricing and distribution, and protected its market position

Alzheimer's

Biotech Company Improves Competitive Awareness and Launch Readiness in Alzheimer’s and Schizophrenia Market

Sedulo GroupCase Studies

In this early‑Alzheimer’s therapeutic space, Sedulo deployed a targeted intelligence initiative combining secondary research and trial data with primary interviews. The result was proactive flagging of competitor R&D moves and potential partnerships, informing strategic planning in a rapidly evolving market.

PAH

Global 2000 Pharma Company Partners with Sedulo for PAH Competitive Landscape Intelligence

Sedulo GroupCase Studies

Leveraging a dual approach of secondary research and Primary Research using Sedulo’s Persistent Source Network™, this project delivered a comprehensive landscape intelligence program for PAH. It mapped evolving competitive pipelines, differentiators, and trial activity to support strategic decision-making in a complex therapeutic area.